2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors

US8673917B2 · kind B2 · utility

Assignee

• Sanofi · FR

Inventors

• Gerhard Zoller · Blankenloch, DE
• Marc Dietrich Voss · Frankfurt am Main, DE
• Hans Matter · Langenselbold, DE
• Andreas Herling · Bad Camberg, DE

Key dates

• Filing date: Sep 2, 2009
• Grant date: Mar 18, 2014
• Expiry date: Sep 2, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compounds of the formula (I), where the groups R1, M, A, B, D, L, and R have the specified meanings, and to the physiologically compatible salts thereof. The compounds are suitable, for example, for treating metabolic syndrome, insulin resistance, obesity, and diabetes.